Consider Ezetimibe as a Statin Add-On
You'll continue to see LESS use of non-statins (niacin, etc) for dyslipidemia...due to limited evidence of CV benefit.
Consider discontinuing non-statins when patients are admitted if there's no good reason for the patient to be on them.
Use these tips to evaluate the need for non-statins.
Get unlimited access through an Enterprise license
Hospital Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 300+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Not sold to individuals